Dr. Karim El Masry, publications

  • Ravi M, Beljorie M, El Masry K. Evaluation of the quantitative fetal fibronectin test and PAMG-1 test for the prediction of spontaneous preterm birth in patients with signs and symptoms suggestive of preterm labor.. J Matern Fetal Neonatal Med. 2018 May 28:1-6. doi: 10.1080/14767058.2018.1476485. [Epub ahead of print]
  • Malik A, Elmasry K, Sayed F, Ravi M. MERS-CoV and pregnancy: a fatal combination.Emerg Infect Dis. 2016 Mar;22(3):515-7. doi: 10.3201/eid2203.151049
  • Fakhreldin M & Elmasry K. Improving the performance of reflex Human Papilloma Virus (HPV) testing for triaging women with atypical squamous cells of undetermined significance (ASCUS): A retrospective study in a tertiary hospital in the United Arab Emirates (UAE). Vaccine. 2016 Feb 3;34(6):823-30. doi: 10.1016/j.vaccine.2015.12.011
  • Elmasry K. Basic, Advanced and Robotic Laparoscopic Surgery. J Obstet Gynaecol. 2011 July; 31(7): 677.
  • Elmasry K, Aswad A. Cervical cancer prevention in Africa: a necessity. Arab Health. 2011: 3: 20-23.
  • Elmasry K. Fast Facts: Gynecologic Oncology. J Obstet Gynaecol. 2011;31(2):201.
  • Siddiqui GK, Maclean AB, Elmasry K, Wong te Fong A, Morris RW, Rashid M, Begent  RHJ, Boxer GM. Immunohistochemical Expression of VEGF Predicts Response to Platinum Based Chemotherapy in Patients with Epithelial Ovarian Cancer. Angiogenesis. 2011 May;14(2):155-61. Epub 2011 Jan 9.
  • Siddiqui GK, Gibson LJ, Elmasry K, Anwar N, Narjis Muzzaffer N, Philippe M. Frossard PM. Ovarian Cancer in Pakistan: Deviance from Established Risk Factors. Submitted to BMC Cancer.
  • Siddiqui GK, Elmasry K, Wong Te Fong AC, Perrett C, Morris R, Crow CC, Maclean AB. Prognostic significance of intratumoural VEGF as a marker of tumour angiogenesis in epithelial ovarian cancer. European Journal of Gynaecological Cancer 2010;31(2):156-9.
  • Elmasry K, Davies AJ, Evans DG, Seif MN, Reynolds K:  Strategies for endometrial screening in the Lynch syndrome population: a patient acceptability study.  Familial Cancer, 2009;8(4):431-9. Epub 2009 Jun 13.
  • Elmasry K*, Ramus S*, Whitaker J, Luo Z, Gammerman A, Lu K, Singh N, Ayhan A, McGluggage G Jacobs I, Gayther S: Genetic Diagnosis and Clinical Outcome in Patients with Synchronous Ovarian and Endometrial Cancer. Clinical Cancer Research, 2008, Sep15; 14(8) 5840-8. (*Joint first authors).
  • Menon U, Harper J, Sharma A, Fraser L, Burnell M, Elmasry K, Rodeck C, Jacobs I. Views of BRCA gene mutation carriers on preimplantation genetic diagnosis as a reproductive option for hereditary breast and ovarian cancer. Hum Reprod. 2007 Jun; 22(6):1573-7.
  • Fiegl H and Elmasry K Cancer diagnosis, risk assessment and prediction of therapeutic response by means of DNA methylation markers. Dis Markers. 2007; 23(1-2):89-96.
  • Elmasry K: Ovarian Cancer Screening: How Do We Pick Up The Silent Disease?  J Fam Plann Reprod Health Care 2006: 32(3).
  • Elmasry K and Gayther S: Ovarian Cancer aetiology: Facts And Fiction. J Fam Plann Reprod Health Care 2006: 32(2) pp 85-8.
  • Elmasry K and Gayther S: Genetic mutations in gynaecological cancers. Reviews in Gynaecological and Perinatal Practice 2006: 6(3) pp115-125.
  • Elmasry K and Gayther S: Epidemiology of Ovarian Cancer in Carcinoma of the Ovary. Edited by Rodney Reznek, Cambridge University Press.
  • Elmasry K and Gayther S: Somatic mutations in gynaecological cancers. Gynaecology Forum 2005 10(1) pp 5-11.

Doctors (1227)